The current institutional shareholding score of C4 Therapeutics Inc is 5.00, ranking 132 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 69.01%, representing a quarter-over-quarter decrease of 2.67%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.52% of shares outstanding, with 13.18% increase in holdings.